Publicaciones
-
Villaverde S, Pedrero-Tomé R, Papaevangelou V, Syridou G, Karagiannidou S, Lyall H, Payne H, Frick MA, Soler-Palacín P, Baquero-Artigao F, Rodríguez-Molino P, Fortuny-Guasch C, Rios-Barnés M, Sánchez-Mateos M, Saavedra-Lozano J, Bringué X, Moliner E, Castells L, Muga O, Vives-Oños I, Gkentzi D, Lombardi G, Tagarro A, Colino E, Couceiro JA, Rojo P, de Vergas J and Blázquez-Gamero D.
Antiviral Treatment and Risk of Hearing Loss in Asymptomatic and Mild Symptomatic Infants With Congenital Cytomegalovirus.
PEDIATRIC INFECTIOUS DISEASE JOURNAL . 44(3): 239-245.
-
Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung CF, Tomlinson J, Stolyarov K, Shchomak Z, Poovorawan Y, Nokes DJ, Munoz-Almagro C, Mandelboim M, Keck JW, Langley JM, Heikkinen T, Deng J, Colson P, Chakhunashvili G, Caballero MT, Bont L, Feikin DR, Nair H, Wang X and Li Y.
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.
NATURE COMMUNICATIONS . 16(1): 1610-1610. Nº de citas: 1
-
Fernandes G, Chappell E, Goetghebuer T, Kahlert CR, Ansone S, Bernardi S, Castelli Gattinara G, Chiappini E, Dollfus C, Frange P, Freyne B, Galli L, Giacomet V, Grisaru-Soen G, Königs C, Lyall H, Marczynska M, Mardarescu M, Naver L, Niehues T, Noguera-Julian A, Stol K, Volokha A, Welch SB, Thorne C and Bamford A.
HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey
HIV MEDICINE . 26(2): 207-217. Nº de citas: 1
-
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szuldrzynski K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Munoz-Almagro C, Milagro AM, Bacci S, Kramarz P and Nardone A.
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)
Vaccine . 45: 126615-126615.
-
Noguera-Julian A, Wilhelmi E, Cussó M, Aarnoutse R, Colbers A, Martorell-Sampol L, López-Ramos MG, Vinent-Genestar J, Rosa Farré Riba, Soy D, Simó-Nebot S and Fortuny-Guasch C.
Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age
ANTIBIOTICS-BASEL . 14(1): .
-
Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Desmet S, Domenech M, Drew R, Plessis MD, Duarte C, Fuursted K, Golden A, Almeida SCG, Henares-Bonilla D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, Ayala MEL, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Munoz-Almagro C, Murdoch D, Musilek M, Novakova L, Oftadeh S, Pérez-Argüello A, Pérez-Vázquez MD, Perrin M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczynska A, Slotved HC, Smith AJ, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Moreno JV, Vohrnova S, von Gottberg A, Yuste J and Brueggemann AB.
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.
LANCET DIGITAL HEALTH . : . Nº de citas: 2
-
Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Munoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, Eugenia León M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacón G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL and Deloria Knoll M.
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
LANCET INFECTIOUS DISEASES . : . Nº de citas: 7
-
Brotons-de los Reyes P, Cisneros M, Pérez-Argüello A, Henares-Bonilla D, Lluansí A, Fernández de Sevilla-Estrach M, Ciruela P, Blanco-Fuertes M, Launes-Montana C, Jordán-García I, Bassat Q, García-García JJ and Munoz-Almagro C.
Pneumococcal nasopharyngeal carriage in children and adults self-confined at home during a COVID-19 national lockdown
PLoS One . 19(12): .
-
González-Anleo C, Girona M, Casaldàliga A, Bobillo-Perez S, Fresán-Ruiz E, Solé-Ribalta A, Velasco E, Manuel Monsonis Cabedo, Urrea M and Jordán-García I.
Risk factors for multidrug-resistant bacteria in critically ill children and MDR score development
EUROPEAN JOURNAL OF PEDIATRICS . 183(12): 5255-5265. Nº de citas: 2
-
Savulescu C, Prats-Uribe A, Brolin K, Lovric Makaric Z, Uusküla A, Panagiotakopoulos G, Bergin C, Fleming C, Agodi A, Bonfanti P, Murri R, Zvirbulis V, Zavadska D, Szuldrzynski K, Machado A, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Petrovic G, Lohur L, Tryfinopoulou K, McGrath J, Ferguson L, Barchitta M, Spolti A, de Gaetano Donati K, Abolina I, Gravele D, Gaio V, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sarajlic G, Amerali M, Sui J, Kenny C, Rapisarda V, Rossi M, Lamonica S, Krievins D, Barzdina EA, Palmira Amaral A, Kosa AG, Miron VD, Munoz-Almagro C, Milagro AM, Bacci S, Kramarz P, Nardone A and The Vebis Hcw Ve Study Group.
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023
Vaccines . 12(11): . Nº de citas: 4